相关实验视频

Updated: Jan 19, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

多尺度转录组学分析显示,MEF2D融合阳性B细胞急性淋巴细胞白血病中MHC抑制

Weina Zhang¹, Yongjing Liu², Xinhua Xiao¹

¹Department of Hematology/Oncology, Guangzhou Medical University Affiliated Women and Children's Medical Center, Guangzhou, China.

Biochemical and biophysical research communications

|January 17, 2026

概括

在B细胞前体急性淋巴细胞白血病 (BCP-ALL) 中的MEF2D基因融合通过降低MHC分子的调节导致发育停止和免疫逃避. 这项研究揭示了一种新的MEF2D-CIITA-MHC致病机制.

科学领域:

血液学血液学血液学
分子生物学分子生物学
免疫学免疫学免疫学

背景情况:

MEF2D基因融合标志着一种独特的B细胞前体急性淋巴细胞白血病 (BCP-ALL) 亚型,预后不佳.
了解驱动这种亚型的分子机制对于开发向疗法至关重要.

研究的目的:

研究MEF2D融合BCP-ALL的分子特征和致病机制.
通过分析基因表达和蛋白质相互作用来确定潜在的治疗点.

主要方法:

在MEF2D融合BCP-ALL病例和公共数据集上进行单细胞RNA测序 (scRNA-seq).
与正常骨髓细胞和其他BCP-ALL亚型细胞的比较.
细胞-细胞通信分析,大量RNA-seq,基因淘汰实验,以及ChIP-seq.

主要成果:

在MEF2D-fusion BCP-ALL.中确定了一个特定的B细胞前发育停止.
观察到主要基因相容性复合体 (MHC) 表达的显著下调,表明免疫逃避.
证实了CIITA (MHC交易激活器) 的下调,并证明MEF2D-HNRNPUL1融合蛋白直接与CIITA的调节区域结合,影响MHC表达.

结论:

MEF2D融合诱导了一个独特的BCP-ALL亚型,其特征是发育停止和免疫逃避.
提出了一种涉及MEF2D-CIITA-MHC通路的新型致病机制.
研究结果提供了MEF2D融合BCP-ALL的生物学见解,并建议针对该途径的潜在治疗策略.

更多相关视频

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

相关概念视频

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...